Leptin and uric acid as predictors of metabolic syndrome in jordanian adults
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Metabolic syndrome (MetS) is a set of interrelated metabolic risk factors that increase the risk of cardiovascular morbidity and mortality. Studies regarding the specificity and sensitivity of serum levels of leptin and uric acid as predictors of MetS are limited. The aim of this study was to evaluate the serum levels of leptin and uric acid in terms of their specificity and sensitivity as predictors of MetS in the studied Jordanian group. SUBJECTS/METHODS: In this cross sectional study, 630 adult subjects (308 men and 322 women) were recruited from the King Hussein Medical Center (Amman, Jordan). The diagnosis of MetS was made according to the 2005 International Diabetes Federation criteria. Receiver operating characteristic curves were used to determine the efficacy of serum levels of leptin and uric acid as predictors of MetS in the studied Jordanian group. RESULTS: Study results showed that for identification of subjects with MetS risk, area under the curve (AUC) for leptin was 0.721 and 0.683 in men and women, respectively. Serum uric acid levels in men showed no significant association with any MetS risk factors and no significant AUC, while uric acid AUC was 0.706 in women. CONCLUSION: Serum leptin levels can be useful biomarkers for evaluation of the risk of MetS independent of baseline obesity in both men and women. On the other hand, serum uric acid levels predicted the risk of MetS only in women.
Abstract
BACKGROUND/OBJECTIVES: Metabolic syndrome (MetS) is a set of interrelated metabolic risk factors that increase the risk of cardiovascular morbidity and mortality. Studies regarding the specificity and sensitivity of serum levels of leptin and uric acid as predictors of MetS are limited. The aim of this study was to evaluate the serum levels of leptin and uric acid in terms of their specificity and sensitivity as predictors of MetS in the studied Jordanian group. SUBJECTS/METHODS: In this cross sectional study, 630 adult subjects (308 men and 322 women) were recruited from the King Hussein Medical Center (Amman, Jordan). The diagnosis of MetS was made according to the 2005 International Diabetes Federation criteria. Receiver operating characteristic curves were used to determine the efficacy of serum levels of leptin and uric acid as predictors of MetS in the studied Jordanian group. RESULTS: Study results showed that for identification of subjects with MetS risk, area under the curve (AUC) for leptin was 0.721 and 0.683 in men and women, respectively. Serum uric acid levels in men showed no significant association with any MetS risk factors and no significant AUC, while uric acid AUC was 0.706 in women. CONCLUSION: Serum leptin levels can be useful biomarkers for evaluation of the risk of MetS independent of baseline obesity in both men and women. On the other hand, serum uric acid levels predicted the risk of MetS only in women.
참고문헌 (62)
- Alberti KG, "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
- van Vliet-Ostaptchouk JV, "The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies", BMC Endocr Disord, 14, pp.9~22 (2014)
- Gallagher EJ, "The metabolic syndrome-from insulin resistance to obesity and diabetes", Endocrinol Metab Clin North Am, 37, pp.559~579 (2008)
- Romao I, "Genetic and environmental interactions in obesity and type 2 diabetes", J Am Diet Assoc, 108, pp.S24~S28 (2008)
- Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation, "World Health Organization (WHO).", World Health Organization, ~ (1999)
- Mabry RM, "Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review", Diabet Med, 27, pp.593~597 (2010)
- Beltrán-Sánchez H, "Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010", J Am Coll Cardiol, 62, pp.697~703 (2013)
- Swinburn BA, "The global obesity pandemic: shaped by global drivers and local environments", Lancet, 378, pp.804~814 (2011)
- Ogden CL, "Prevalence of obesity in the United States, 2009-2010", NCHS Data Brief, pp.1~8 (2012)
- Manjunath D, "Metabolic syndrome among urban Indian young adults:prevalence and associated risk factors", Metab Syndr Relat Disord, 12, pp.381~389 (2014)
- Ford ES, "A comparison of the prevalence of the metabolic syndrome using two proposed definitions", Diabetes Care, 26, pp.575~581 (2003)
- Chuengsamarn S, "Association between metabolic syndrome and risk of cardiovascular disease, using different criteria and stratified by sex", Int J Diabetes Mellit, 2, pp.78~82 (2010)
- van Beek EA, "Intra- and interindividual variation in gene expression in human adipose tissue", Pflugers Arch, 453, pp.851~861 (2007)
- Kelesidis T, "Narrative review: the role of leptin in human physiology: emerging clinical applications", Ann Intern Med, 152, pp.93~100 (2010)
- Özçelik E, "Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome", Diabetes Metab Syndr, 4, pp.13~17 (2010)
- Yun JE, "Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations", Metabolism, 59, pp.424~429 (2010)
- Björntorp P., "Hypertension and the Metabolic Syndrome: closely related central origin?", Int Congr Ser, 1241, pp.81~86 (2002)
- Ukkola O, "Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects", Metabolism, 56, pp.1221~1227 (2007)
- Martin SS, "Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease", J Am Coll Cardiol, 52, pp.1201~1210 (2008)
- Thorand B, "Associations between leptin and the leptin", adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA, Diabet Med, pp.2010, 27[DOI]
- Wallace AM, "Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)", Circulation, 104, pp.3052~3056 (2001)
- Li WC, "Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults", Cardiovasc Diabetol, 10, pp.36~42 (2011)
- Ingelsson E, "Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample", J Clin Endocrinol Metab, 93, pp.3149~3157 (2008)
- Numata T, "Comparison of serum uric acid levels between Japanese with and without metabolic syndrome", Diabetes Res Clin Pract, 80, pp.e1~e5 (2008)
- de Oliveira EP, "High plasma uric acid concentration:causes and consequences", Diabetol Metab Syndr, 4, pp.12~19 (2012)
- Nakagawa T, "A causal role for uric acid in fructose-induced metabolic syndrome", Am J Physiol Renal Physiol, 290, pp.F625~F631 (2006)
- Lee MS, "High prevalence of hyperuricemia in elderly Taiwanese", Asia Pac J Clin Nutr, 14, pp.285~292 (2005)
- Ford ES, "Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents", Circulation, 115, pp.2526~2532 (2007)
- Sui X, "Uric acid and the development of metabolic syndrome in women and men", Metabolism, 57, pp.845~852 (2008)
- Chiou WK, "The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese", J Epidemiol, 20, pp.219~224 (2010)
- Liu M, "Association between serum uric acid level and metabolic syndrome and its sex difference in a chinese community elderly population", Int J Endocrinol, pp.754678~ (2014)
- Billiet L, "Review of hyperuricemia as new marker for metabolic syndrome", ISRN Rheumatol, pp.852954~ (2014)
- Sheikhbahaei S, "Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes", Metab Syndr Relat Disord, 12, pp.102~109 (2014)
- Lin JD, "Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid", Metabolism, 56, pp.751~756 (2007)
- Liu PW, "Serum uric acid and metabolic syndrome in Taiwanese adults", Metabolism, 59, pp.802~807 (2010)
- Longo-Mbenza B, "Is uric acid a surrogate and additional component of incident metabolic syndrome, insulin resistance among inactive Central Africans?", Diabetes Metab Syndr, 4, pp.74~81 (2010)
- Kaur J., "A comprehensive review on metabolic syndrome", Cardiol Res Pract, pp.943162~ (2014)
- Obeidat AA, "Evaluation of several anthropometric indices of obesity as predictors of metabolic syndrome in Jordanian adults", Nutr Hosp, 32, pp.667~677 (2015)
- Ajlouni K, "Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors", J Intern Med, 244, pp.317~323 (1998)
- Centers for Disease Control and Prevention (CDC), "Prevalence of selected risk factors for chronic disease--Jordan, 2002", MMWR Morb Mortal Wkly Rep, 52, pp.1042~1044 (2003)
- Centers for Disease Control and Prevention (CDC), "Assessing risk factors for chronic disease--Jordan, 2004", MMWR Morb Mortal Wkly Rep, 55, pp.653~655 (2006)
- Hammoudeh AJ, "Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS)", Int J Cardiol, 110, pp.179~183 (2006)
- Khader Y, "High prevalence of the metabolic syndrome among Northern Jordanians", J Diabetes Complications, 21, pp.214~219 (2007)
- Al-Odat AZ, "References of anthropometric indices of central obesity and metabolic syndrome in Jordanian men and women", Diabetes Metab Syndr, 6, pp.15~21 (2012)
- Obeidat BA, "Predictors of metabolic syndrome among employees: a study from Jordan", Food Nutr Sci, 3, pp.669~677 (2012)
- "The IDF consensus worldwide definition of the metabolic syndrome" (2006)[URL]
- "National Health and Nutrition Examination Survey: anthropometry and physical activity monitor procedures manual" (2005)[URL]
- Lee RD, "Nutritional Assessment" (2010), McGraw-Hill Education
- Chen H, "Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model", Diabetes, 54, pp.1914~1925 (2005)
- Akobeng AK., "Understanding diagnostic tests 3: receiver operating characteristic curves", Acta Paediatr, 96, pp.644~647 (2007)
- Canatan H, "Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects", Endocr Res, 30, pp.95~105 (2004)
- Lyoussi B, "Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans", Clin Exp Hypertens, 27, pp.377~394 (2005)
- Hamed M., "Serum uric acid and leptin levels in metabolic syndrome", Int J Pharm Sci Rev Res, 20, pp.21~27 (2013)
- Correia ML, "Obesity-related hypertension: is there a role for selective leptin resistance?", Curr Hypertens Rep, 6, pp.230~235 (2004)
- Lee CY, "Association between serum leptin and adiponectin levels with risk of insulin resistance and impaired glucose tolerance in non-diabetic women", Kaohsiung J Med Sci, 25, pp.116~125 (2009)
- Zhuo Q, "Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities", Diabetes Res Clin Pract, 84, pp.27~33 (2009)
- Chien KL, "Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study", Atherosclerosis, 183, pp.147~155 (2005)
- Milionis HJ, "Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia", Am Heart J, 148, pp.635~640 (2004)
- Solymoss BC, "Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity", Am J Cardiol, 93, pp.159~164 (2004)
- Yoo TW, "Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome", Circ J, 69, pp.928~933 (2005)
- Ishizaka N, "Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals", Arterioscler Thromb Vasc Biol, 25, pp.1038~1044 (2005)
- Rho YH, "Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database", Metabolism, 57, pp.71~76 (2008)
